Renalytix Plc (RENX.L) LSE

3.88

+0.125(+3.33%)

Updated at February 20 01:22PM

Currency In GBp

Valuation

Market Cap9.68M
Enterprise Value14.38M
P/E Ratio-0.33
PEG Ratio-0.02
Price/Sales Ratio9.85
Price/Book Ratio-1.43
Enterprise/Revenue11.53
Enterprise/EBITDA-0.93

Fiscal Year

Fiscal YearJune 30, 2025
Most Recent QuarterDecember 31, 2024

Profitability

Profit Margin-14.62
Operating Margin-12.93

Management Effectiveness

Return On Assets-4.2
Return On Equity-6.31

Income Statement

Revenue3M
Revenue/Share0.04
Gross Profit1.2M
EBITDA-21.3M
Net Income-20.4M
Diluted EPS-0.21

Balance Sheet

Total Cash9.63M
Total Cash/Share0.09
Total Debt8.21M
Total Debt/Equity-1.09
Current Ratio0.53
Book Value Per Share-0.15

Price History

52-Week Change-66.3
52-Week High15.5
52-Week Low3.74
Moving Average 50 Days5.88
Moving Average 200 Days7.05

Statistics

Average Volume599,385
Shares Outstanding331.93M
% Held by Institutions0.24

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A